ALTICE USA ($ATUS) is expected to release its quarterly earnings data on Thursday, February 13th before market open, per Finnhub. Analysts are expecting revenue of $2,284,721,072 and earnings of $0.04 per share.
You can see Quiver Quantitative's $ATUS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALTICE USA Insider Trading Activity
ALTICE USA insiders have traded $ATUS stock on the open market 126 times in the past 6 months. Of those trades, 0 have been purchases and 126 have been sales.
Here’s a breakdown of recent trading of $ATUS stock by insiders over the last 6 months:
- ALT S.A.R.L. NEXT has made 0 purchases and 126 sales selling 33,819,573 shares for an estimated $828,579,538.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ALTICE USA Hedge Fund Activity
We have seen 70 institutional investors add shares of ALTICE USA stock to their portfolio, and 88 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CLARKSTON CAPITAL PARTNERS, LLC removed 30,353,434 shares (-97.2%) from their portfolio in Q3 2024, for an estimated $74,669,447
- FMR LLC removed 11,028,164 shares (-34.6%) from their portfolio in Q3 2024, for an estimated $27,129,283
- NOMURA HOLDINGS INC added 11,000,561 shares (+inf%) to their portfolio in Q3 2024, for an estimated $27,061,380
- DIAMETER CAPITAL PARTNERS LP added 6,862,540 shares (+164.9%) to their portfolio in Q3 2024, for an estimated $16,881,848
- BRACEBRIDGE CAPITAL, LLC added 6,532,640 shares (+inf%) to their portfolio in Q3 2024, for an estimated $16,070,294
- DEUTSCHE BANK AG\ added 5,650,265 shares (+167.5%) to their portfolio in Q3 2024, for an estimated $13,899,651
- RAYMOND JAMES & ASSOCIATES removed 3,707,866 shares (-99.5%) from their portfolio in Q3 2024, for an estimated $9,121,350
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
